Hologic Analysts Boost Their Forecasts After Q3 Results
Hologic, Inc. HOLX reported upbeat earnings for its third quarter, but issued soft guidance on Monday.
Hologic, Inc. (HOLX) Q3 2024 Earnings Call Transcript
Hologic, Inc. (NASDAQ:HOLX ) Q3 2024 Earnings Conference Call July 29, 2024 4:30 AM ET Company Participants Ryan Simon - VP, IR Stephen MacMillan - Chairman, President & CEO Essex Mitchell - COO Karleen Oberton - CFO Conference Call Participants Patrick Donnelly - Citi Tejas Savant - Morgan Stanley Jack Meehan - Nephron Research Vijay Kumar - Evercore Anthony Petrone - Mizuho Securities Michael Matson - Needham & Company Casey Woodring - JPMorgan Michael Ryskin - Bank of America Navann Ty - BNP Paribas Ryan Zimmerman - BTIG Mason Carrico - Stephens Andrew Cooper - Raymond James Puneet Souda - Leerink Partners Operator Good afternoon, and welcome to the Hologic's Third Quarter Fiscal 2024 Earnings Conference Call. My name is Cynthia, and I am your operator for today's call.
Compared to Estimates, Hologic (HOLX) Q3 Earnings: A Look at Key Metrics
The headline numbers for Hologic (HOLX) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Hologic quarterly profit rises on strong demand for its women's health products
Medical technology company Hologic reported a higher third-quarter profit on Monday, driven by strong demand for its diagnostics and breast health products, but forecast revenue for the current quarter that fell short of Wall Street estimates.
Hologic (HOLX) Q3 Earnings and Revenues Top Estimates
Hologic (HOLX) came out with quarterly earnings of $1.06 per share, beating the Zacks Consensus Estimate of $1.02 per share. This compares to earnings of $0.93 per share a year ago.
HOLX or SONVY: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical - Instruments sector have probably already heard of Hologic (HOLX) and SONOVA HOLDING (SONVY). But which of these two stocks offers value investors a better bang for their buck right now?
Hologic (HOLX) Buys Endomag to Boost Breast Cancer Solutions
Hologic (HOLX) acquires Endomag for $310M, enhancing its breast cancer surgery portfolio with innovative technologies like Magseed and Magtrace, aiming to improve patient care and outcomes globally.
Gear Up for Hologic (HOLX) Q3 Earnings: Wall Street Estimates for Key Metrics
Evaluate the expected performance of Hologic (HOLX) for the quarter ended June 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Hologic (HOLX) Advances But Underperforms Market: Key Facts
In the latest trading session, Hologic (HOLX) closed at $78.38, marking a +0.35% move from the previous day.
Hologic's (HOLX) Surgical Business Set to Propel Q3 Earnings
Hologic (HOLX) is likely to have delivered impressive performances across the GYN Surgical and Breast Health businesses in the third quarter of fiscal 2024.
Pre Q3 Earnings: Is Hologic (HOLX) Stock a Portfolio Must-Have?
Hologic (HOLX) benefits from its unique set of businesses, each underpinned by its durable growth drivers. The impressive YTD price rally, earnings prowess and attractive valuation make the stock a top investment pick.
Hologic (HOLX) Exceeds Market Returns: Some Facts to Consider
Hologic (HOLX) closed the most recent trading day at $78.46, moving +1.45% from the previous trading session.
